NASDAQ:SLS

Sellas Life Sciences Group Stock Predictions

etoro logo Buy SLS
*Your capital is at risk
$8.23
-0.81 (-8.96%)
At Close: Jun 05, 2026
Currently predicting for Mon, 8 Jun 2026

SLS Prediction Chart

SLS Predictions History

Latest community submissions for SLS.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Feb 4, 2021 $9.99 +1.94% $9.80 X 98.06% 1
ALBERT MOSSERI ALBERT MOSSERI @ALBERTMOSSERI.198543
Feb 4, 2021 Bullish $9.80 X 1
JS JS Pro
Dec 11, 2020 $15.23 +81.96% $8.37 X 18.04% 1
Rick Murphy Rick Murphy @RickMurphy.172536
Dec 11, 2020 $4.59 -45.16% $8.37 X 54.84% 0
Dec 11, 2020 Bullish $8.37 X 1
JS JS Pro
Dec 8, 2020 $3.58 -2.98% $3.69 X 97.02% 0
Shawn Lim Shawn Lim @ShawnLim.180975
Dec 8, 2020 Bullish $3.69 X 0
JS JS Pro
Dec 7, 2020 $3.92 +6.23% $3.69 X 93.77% 0
JS JS Pro
Dec 4, 2020 $3.70 -4.15% $3.86 X 95.85% 0
Mr. B Mr. B @Mr.B.180287
Dec 4, 2020 Bearish $3.86 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SLS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SELLAS LIFE SCIENCES GROUP INC.
SELLAS Life Sciences Group
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE